CompletedNot Applicable

Assessment Of Peri-papillary Retinal Nerve Fiber Layer Thickness In Patients With Unilateral Branch Retinal Vein Occlusion

Egypt60 participantsStarted 2020-12-01

Plain-language summary

Several studies have indicated a relation between the development of RVO and elevated intraocular pressure (IOP) and glaucoma \[9\]. Further investigations into the structural alterations in the fellow eyes of individuals with unilateral RVO have revealed that the pRNFL is thinner than in healthy eyes, suggesting that there may be systemic risk factors for both RVO and glaucoma

Who can participate

Age range47 Years – 68 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with unilateral BRVO Exclusion Criteria: * History of retinal and/or optic nerve diseases involving glaucomatous optic disc, ischemic optic neuropathy, or optic neuritis. * History of trauma, intravitreal injections, vitreoretinal surgeries, and retinal or macular lasers. * A significant media opacity that makes it difficult to capture clear images. * No history of diabetes and/or hypertension in those recruited as the control group

What they're measuring

peri-papillary retinal nerve fiber layer thickness

Timeframe: Base line

peri-papillary retinal nerve fiber layer thickness

Timeframe: 6 months post injection

peri-papillary retinal nerve fiber layer thickness

Timeframe: 12 months post injection

peri-papillary retinal nerve fiber layer thickness

Timeframe: 24 months post injection

Trial details

NCT IDNCT06146309

SponsorAl-Azhar University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-07-20

View on ClinicalTrials.gov More Branch Retinal Vein Occlusion trials